Made in DP success for dermatology research company Ziarco
Posted on 16/12/16
Discovery Park has long been a global centre for research with dermatology R&D experts Ziarco the latest to proudly wear the label #MadeinDP.
Earlier today the company announced its sale to Novartis, one of the world’s biggest pharmaceutical companies.
Ziarco’s key asset is lead investigational product, ZPL389, a potential first-in-class oral treatment for moderate-to-severe eczema.
The sale is a success story for Ziarco’s founders, four R&D leaders who spun out the company from Pfizer after the company scaled back its operations in 2011.
Read more on this story on the Ziarco website .